Search - tctmd.com

Displaying 101 - 120 of 169

Sort: Relevancy | Date

News Daily News

US Sees Drop in Hypertension Control

Todd Neale

September 10, 2020

News Daily News

GATEWAY at 3 Years: Bariatric Surgery Continues to Reduce Need for Antihypertensive Drugs

L.A. McKeown

August 31, 2020

News Daily News

US Mortality Rates for CVD Have Stalled as Racial Disparities Widen

Yael L. Maxwell

August 19, 2020

News Daily News

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Michael O'Riordan

August 13, 2020

News Daily News

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Michael O'Riordan

July 16, 2020

News Features

COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention

Michael O'Riordan

April 24, 2020

News Daily News

Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease

Michael O'Riordan

March 13, 2020

News Daily News

FDA Approves New Lipid-Lowering Drug, Bempedoic Acid

Shelley Wood

February 26, 2020

News Daily News

Free Pass? Lifestyle Slips for Patients Starting Certain Preventive Meds

Michael O'Riordan

February 06, 2020

News Daily News

AHA Plugs ‘Dietary Patterns’ Over Dietary Cholesterol Targets

Yael L. Maxwell

December 26, 2019

News Daily News

Non-HDL Cholesterol Strongly Tied to Lifetime CVD Risk

Michael O'Riordan

December 03, 2019

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

News Daily News

Evolocumab Safe and Effective Out to 5 Years: OSLER-1

Yael L. Maxwell

October 22, 2019

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2019

Shelley Wood

October 01, 2019

News Conference News ESC 2019

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

Michael O'Riordan

September 04, 2019

News Conference News ESC 2019

Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4

Michael O'Riordan

September 02, 2019

News Conference News ESC 2019

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

Shelley Wood

August 31, 2019

News Daily News

New AHA Guidance on Omega-3 Fatty Acids for High Triglycerides

Michael O'Riordan

August 21, 2019

News Daily News

DAPA-HF: Dapagliflozin Scores a Win in Heart Failure

Todd Neale

August 20, 2019

Advertisement

US Sees Drop in Hypertension Control

GATEWAY at 3 Years: Bariatric Surgery Continues to Reduce Need for Antihypertensive Drugs

US Mortality Rates for CVD Have Stalled as Racial Disparities Widen

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Higher Risk of HF After ACS for Women Previously on Beta-blockers

COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention

Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease

FDA Approves New Lipid-Lowering Drug, Bempedoic Acid

Free Pass? Lifestyle Slips for Patients Starting Certain Preventive Meds

AHA Plugs ‘Dietary Patterns’ Over Dietary Cholesterol Targets

Non-HDL Cholesterol Strongly Tied to Lifetime CVD Risk

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Evolocumab Safe and Effective Out to 5 Years: OSLER-1

Recurrent Events Common Among Young Patients With CAD

TCTMD’s Top 10 Most Popular Stories for September 2019

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

New AHA Guidance on Omega-3 Fatty Acids for High Triglycerides

DAPA-HF: Dapagliflozin Scores a Win in Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content